64
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies

, , , , &
Pages 1819-1831 | Published online: 01 Jun 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (5)